Objective: To compare long-term results of the European Homograft Bank (LHB) cryopreserved pulmonary homograft in left ventricular out¯ow tract (LVOT) subjected to pulmonary hypertension with those subjected to normal pulmonary pressure. The mid-term study of this material published in 1997 showed different results. Methods: Ninety EHB cryopreserved PHG were used for LVOT reconstruction in different European centres between May 1989 and December 1995. PHGs were classi®ed in two groups: (1) Pulmonary hypertension PHG (procured from recipients of heart/heart-long transplantation) and (2) Normal pulmonary pressure PHG (procured from multiorgan donors and cadavers). Signi®cant echocardiography changes were de®ned as a stenosis with gradient of more than 30 mmHg and/or insuf®ciency of . 2 1 . Statistical analysis is calculated by the Kaplan±Meier survival curves, while differences in prevalence by the Log-Rank test. Results: Follow-up (FU) was available in 69 cases (76.7%): 46 in group 1 and 23 in group 2. Five patients have been excluded from the study because of early homograft explantation (technical problems or early valve incompetence). Fourteen out of 43 cases of group 1 (32.6%) and seven out of 21 cases of group 2 (33.3%) have been explanted after 2.5±88 months and 7±88 months, respectively. Signi®cant echography changes have been found in 19 of 43 (44.18%) of group 1 and 11 of 21 cases (52.38%) of group 2 during the follow-up. Histology showed essentially wear and tear induced lesions. Mean FU was 36.9 (range, 6±88) and 41.3 months (range, 4±88) for group 1 and 2, respectively. No signi®cant difference in the long-term outcome have been found between the two groups (P 0:38). Conclusion: Contrary to our previous echocardiography study of mid-term implants the long-term follow up of the PHGs implanted in the LVOT did not show better function of the pulmonary homografts subjected to pulmonary hypertension than those with normal pulmonary pressure. The high failure rate of the PHGs should discourage their use for LVOT reconstruction. Further echocardiography studies of remaining PHGs implanted in the LVOT, and gross and microscopic explant studies are required to judge on the de®nitive outcome of these grafts. q
Introduction
Considering the excellent long-term results with the pulmonary autograft used for reconstruction of the left ventricular out¯ow tract [1, 2] and according to the investigations of Gorczynski [3] and Gerosa [4] , which proved that the PHG can withstand higher mechanical stress in systemic circulation, many cardiac surgeons have used the pulmonary homograft, rather than autograft, for reconstruction of the left ventricular out¯ow tract (LVOT). The latest considering the invasivity of the Ross procedure. However, use of a cryopreserved pulmonary homograft for this purpose has many controversies and is at the present time almost completely abandoned for elective cases [4, 5] . During the early 1990s this method was rather popular and many European Heart Surgery centres have reported implantation of this EHB graft in several cases [4±10] .
During the procurement of the human heart valves, one have observed macroscopic differences between the European Journal of Cardio-thoracic Surgery 17 (2000) 140±145 pulmonary homografts, related to pulmonary hypertension and those with normal pulmonary pressure [7] which correspond with the earlier publications of Davies [11] and Wagenvoort [12] . This was one of the reasons which encouraged us to study the clinical course and compare these two groups of the PHGs.
Earlier we have published mid-term results of the multicentric echography study of the 52 pulmonary homografts used for LVOT reconstruction, comparing the PHGs related to pulmonary hypertension with those related to normal pulmonary pressure [7] . The aim of this study was to compare the long-term echography outcome of these two groups of cryopreserved homografts. The mid-term results of a comparable group published by the same institution in 1997 have shown a different results.
Materials and methods

Pulmonary homografts and patient data
A total of 90 EHB cryopreserved PHGs have been implanted in the LVOT in different European Cardiac Surgery centres between May 1989 and December 1995. The recipient age varied from 7 days to 80 years (mean age 41.5 years). Sixty-three patients were male and 27 female (ratio 2.3:1). The indications for operation were: infective valvulopathy in 14 cases, congenital aortic valve pathology in 23 cases and active native or prosthetic valve endocarditis in 53 cases. Follow-up data have been completed for 69 (76.7%) cases which have been echographically studied and the results have been analyzed on longterm period of time.
Pulmonary homografts of the 69 presented cases have been implanted in a subcoronary position in 60 cases whereas a mini-root or total root replacement in was performed in nine cases.
Classi®cation of the homografts
According to the donor category PHGs have been classi®ed in two groups: in group 1 were the pulmonary hypertension homografts (46 cases), where the PHGs were with the thickened cusps, procured from a recipients of the heart/ heart-long transplantation; in group 2 were the normal pulmonary artery pressure pulmonary homografts (23 cases), where the PHGs had macroscopically normal cusps, procured from the multiorgan donors (MOD) or cadavers.
FU data
The implanting surgeons and/or cardiologists were requested to send us clinical and echocardiographic follow-up ®ndings on regular basis (every 6 months to 1 year). Mean FU was 36.9 months (range, 2.5±88 months) for group 1, and 41.3 months (range, 7±88 months) for group 2.
The size of the implanted valves was between 16 and 30 mm with the majority between 23 and 25 mm. Seventy-nine percent were between 21 and 28 mm (Fig. 1) .
Signi®cant echography changes were de®ned as a stenosis with the pressure gradient of .30 mmHg and/or insuf®-ciency of .2/4.
All explanted PHGs have been sent back to the EHB for histological examination.
Statistical analysis
Statistical analysis was performed using Kaplan±Meier survival curves. Differences in prevalence are calculated by the Log-Rank test (P . 0:05).
Results
Follow-up was available in 69 cases (76.7%): 46 of group 1 and 23 of group 2. Five patients, three from group 1 and two of group 2, have been excluded from the study because of early explantation (technical problems or early massive valve incompetence). Fourteen of 43 homografts of group 1 (32.6%) and seven from 21 of group 2 (33.3%) have been explanted after 2.5±88 and 7±88 months, respectively. The main reasons of explantation were massive homograft regurgitation as a result of recurrence of endocarditis, cusp devitalization, cusp perforation or calci®cation of the PHG in both groups. Five cases (four of group 1 and one of group 2) had recurrence of endocarditis, seven cases (®ve of group 1 and two of group 2) had cusp devitalization, six cases (three homografts of each group) had cusp perforation, while four cases (one of group 1 and three of group 2) had cusp calci®cation (Table 1 ). All explanted PHGs had at the last echography examination massive regurgitation with or without heart decompensation. Almost all explanted homografts were sent back to the EHB for histological examina-tion. This showed essentially wear and tear induced lesions of the homograft lea¯ets [19] .
On the FU echography study 19 of 43 cases of group 1 (44.18%) and 11 of 21 cases of group 2 (52.38%), (including the 21 explanted valves: 14 of group 1 and seven of group 2) have shown signi®cant echography changes after long-term period of implantation.
The relationship between explanted homografts regarding to the valve diameter was the following: one, ten and three homografts of the diameter category of 19±22, 23±26 and 27±30 mm have been explanted after 36, 4±88 and 29.5±88 months, respectively, in a group with pulmonary hypertension, compared with ®ve and two homografts of diameter category 23±26 and 27±30 mm after 7±68 and 42±45 months, respectively, in a group with the normal pulmonary pressure.
The homografts still implanted gave following echography results per diameter group: in perfect state were still four, eight and three homografts of the diameter category 19±22, 23±26 and 27±30 mm after 74±88, 36±80 and 60±70 months, respectively, in a group with pulmonary hypertension, whereas two, three and two homografts, diameter category of 19±22, 23±26 and 27±30 mm, after 60±84, 37±60 and 27±52 months, respectively, in a group with normal pulmonary pressure. In the same group, signi®cant echography changes showed two, ten and two homografts after 36± 88, 50±88, 55±70 months, for diameter category 19±22, 23± 26 and 27±30 mm, respectively, in a group with pulmonary hypertension, whereas two, three and two homografts of a diameter category 19±22, 23±26 and 27±30 mm, showed signi®cant echography changes after 60±84, 27±60 and 27±52 months, respectively, in a group with normal pulmonary pressure (Fig. 2) .
Discussion
Aortic valve replacement with human aortic valve allografts has demonstrated bene®t because of the superior haemodynamic performance, excellent treatment for endocarditis, freedom from anticoagulation, very infrequent thromboembolic complications and good long-term durability [8,9,13±15] . However, shortage in aortic homografts because of limited number of donors and early atherosclerotic changes of the aortic valves, resulting in a very high rate of the discarded aortic homografts during the procurement [5, 7, 9] , lead to searching for the other possibilities for LVOT reconstruction in young patients, patients with severe endocarditis and those with contraindication for anticoagulation.
Since the biomechanical studies of Gorczynski [3] and Gerosa [4] have proved that the pulmonary homograft can withstand higher mechanical stress in systemic circulation, and considering the excellent results of the pulmonary autografts on left position (Ross procedure) [1,2,10,16,17], many European Cardiac Surgery centres have used pulmonary homograft as an aortic valve substitute, considering this operation less invasive than the Ross procedure. On the other hand, a very similar morphology of the pulmonary with the aortic valve [20] was an argument more for establishing the use of the pulmonary homograft for reconstruction of the LVOT. Following the initial implantations, very good results on short and mid-term period have been published by Gerosa [4] , Luppinetti [8] and Mair [18] .
However, long-term studies of pulmonary homografts used for the LVOT reconstruction were not very satisfying [5, 8, 9] and most cardiac surgery centres have almost completely abandoned this method. Several studies have been published on the long-term behaviour of the pulmonary homografts. Following Mair [5] higher incidence of endocarditis has been noted in the PHG from the donors older than 50 years. Also higher incidence of the valve regurgitation early after implantation has been seen at this category of the homografts. According to his long-term results, there were not arguments for using of the PHGs in the LVOT any more. MacCarthy showed a higher incidence of valve failure in case of pulmonary homograft, comparing to the aortic homograft and pulmonary autograft used as the aortic valve substitute [9] . According to his results, pulmonary homograft should be reserved only for the patients with bacterial endocarditis when the aortic homograft is not available, and he advocates the intra-aortic cylinder technique to minimize lea¯et distension and achieve good coaptation.
Since a considerable number of the EHB cryopreserved PHGs have been implanted in the LVOT according to different indications, we have been studying the echographic behaviour of this group of the homografts during a period of 10 years. The pulmonary homografts have been divided in the two above-mentioned groups, according to the morphologic appearance on procurement and the type of the donor. Short-and mid-term results of this category of homografts have been earlier presented at the Meeting of the EACTS in Paris in 1995 and published in 1997 by this group of authors, and have shown different results [7] , compared with the long-term results presented at this paper.
The distinction between the two groups has been made because of a spectrum of the donor pathology and, consequently, the haemodynamic conditions to which the valves are subjected. They are similar in cadavers and multiorgan donors, while completely different in transplantation cases. In fact, in transplantation cases the majority of the donor pathology involves a pulmonary hypertension, either active or passive, whereas this is not observable in cadavers and multiorgan donors [7] .
Considering the different morphologic appearance of the PHGs subjected to pulmonary hypertension and those subjected to normal pulmonary pressure, a comparative short and midterm study of those two groups of cryopreserved homograft valves has shown that the PHGs subjected to pulmonary hypertension could be better than those subjected to normal pulmonary pressure, according to the physiologic circumstances related to pulmonary hypertension. These homografts showed indeed, better results for pulmonary hypertension group (group 1) on short and mid-term period of time (7 vs. 10%, 27 vs. 37.5% and 33 vs. 80 % echographic changes after 12, 24 and 36 months, respectively). Further FU echographic examinations of the implanted homografts have been done in the implanting centres, whereas the histologic studies of the explanted PHGs have been performed at the EHB [19] . Long-term FU of the implanted valves in the different centres have not proved our earlier predictions.
Although one should expect different behaviour of these two homograft valves, according to the different haemodynamic circumstances of the donors, no signi®cant differences in durability and competence have been found in long-term echography FU. Moreover, the main reasons of explantation were similar for both groups.
So far we haven't found in the literature any similar study which could be used as a comparative study with our results. 
Conclusion
Contrary to our previous echography study of midterm implants, the long-term follow up of the PHGs, implanted in the LVOT, did not show a better function of the homografts subjected to pulmonary hypertension than those with normal pulmonary pressure. The failure rate of both groups of the PHG is too high to justify their use for LVOT reconstruction.
The main ®nding after long-term implantation is homograft failure, related to wear and tear mechanisms.
Further echography and histological studies of the explanted valves are required for remaining PHG implanted on the LVOT to conclude de®nitive outcome of these cryopreserved homografts.
Comment
This study has some limitations: (1) it shows quite poor completion of FU data. The main reason is that some of implanting centres didn't accept participation in the study. The problem of poor FU data has been already discussed earlier at the last Symposium of the EHB:`10 Years Experience With EHB Homograft Valves & Arteries' [21] ; (2) the number of implanted allografts of this category for reconstruction of the LVOT was limited. Only 90 homografts of this category have been sent from our Institution to the European Cardiac Surgery centres.
